health ๐ฌ FDA approves first mRNA flu vaccine for seniors
The FDA has approved mFlusiva, the first mRNA flu vaccine in the US, offering a new option for adults aged 50 and older for the 2026โ2027 season. Moderna is rolling this out with full approval for ages 50 to 64 and accelerated approval for those 65 and up. The approval followed trials involving over 40,000 adults across 11 countries. This vaccine is faster to produce than traditional egg-based shots and showed 27% higher effectiveness in trials. Further studies are ongoing for younger age groups to broaden the approval. ๐ฌ